The clinical supply of cell and gene therapy drugs: Challenges ahead

Drug Discov Today. 2023 Feb;28(2):103421. doi: 10.1016/j.drudis.2022.103421. Epub 2022 Oct 26.

Authors

Thomas Fehm¹, Philip Boehme², Nehal Modak³, Vaibhav Talwar⁴, Kristian Kinscher⁵

Affiliations

¹ McKinsey & Co., Chicago, USA.
² McKinsey Alumnus, Germany; University Witten/Herdecke, Germany.
³ McKinsey & Co, London, UK.
⁴ McKinsey & Co., NJ, USA.
⁵ McKinsey & Co., Düsseldorf, Germany; University Witten/Herdecke, Germany. Electronic address: kristian_kinscher@mckinsey.com.

PMID: 36309192
DOI: 10.1016/j.drudis.2022.103421

No abstract available

Keywords: CDMO; CRO; clinical supply; gene and cell therapy products; new modalities.

Publication types

Editorial

MeSH terms

Repressor Proteins*
Viral Proteins*

Substances

Repressor Proteins
Viral Proteins